TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive Coalition Gives “Incomplete” To NCI, CDC Statistics, But Gets Low Grade From Critics March 20, 1998
TCL Archive Cancer Telethon Attracts Small Audience, Generates Expectations-And Questions. September 12, 2008
TCL Archive FDA’s Commitment To Cancer No Different Than Other Diseases, Kessler Tells Advocate August 14, 1992
TCL Archive Klausner, Nathan Discuss Challenge of Cancer Research In the “Post-Genome World” January 15, 1999
